Related Experiment Video

Updated: May 26, 2026

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Gestational medication use, birth conditions, and early postnatal exposures for childhood asthma

Yang-Ching Chen1, Ching-Hui Tsai, Yungling Lee

  • 1Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.

Clinical & Developmental Immunology
|December 29, 2011
PubMed

Insights

Gestational medication use and early postnatal exposures like daycare attendance are linked to childhood asthma. Exclusive breastfeeding offers protection against this common respiratory condition.

Area of Science:

  • Pediatric Epidemiology
  • Environmental Health
  • Respiratory Medicine

Background:

  • Childhood asthma is a significant public health concern.
  • Understanding environmental and prenatal risk factors is crucial for prevention strategies.

Purpose of the Study:

  • To investigate correlations between gestational medication use, delivery mode, and early postnatal exposures with childhood asthma.
  • To assess dose-response relationships and differential impacts on early- and late-onset asthma.

Main Methods:

  • A matched case-control study utilizing data from the Taiwan Children Health Study.
  • Telephone interviews with 579 mothers of participants aged 12-14 years.
  • Analysis of factors including maternal medication use, delivery mode, infections, hospitalization, caregiver status, and daycare attendance.

Main Results:

  • Exclusive breastfeeding demonstrated a protective effect against childhood asthma.
  • Significant associations were found between asthma and maternal medication use during pregnancy, vacuum-assisted vaginal delivery, recurrent respiratory infections, hospitalization, having a caregiver with other children, and early daycare attendance.
  • Dose-response relationships were observed for these exposures, with most showing a greater impact on early-onset asthma.

Conclusions:

  • Maternal medication use during pregnancy and specific early postnatal exposures are significant risk factors for childhood asthma.
  • Exclusive breastfeeding is a protective factor.
  • Interventions targeting these modifiable risk factors may help reduce childhood asthma incidence.

More Related Videos

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale19:15

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale

Published on: August 25, 2014

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: